Ou et al., 2021 - Google Patents
Enhanced targeting and immune activation of tumor microenvironment by nanomodified Anti‐PD1 in liver cancerOu et al., 2021
- Document ID
- 6053813254348986076
- Author
- Ou D
- Tseng S
- Kempson I
- Hsu C
- Yang P
- Liao Z
- Publication year
- Publication venue
- Advanced Therapeutics
External Links
Snippet
Liver cancer is one of the most common cancers worldwide, 75% of which are hepatocellular carcinoma (HCC). Generally, chronic inflammation and an immunosuppressive tumor microenvironment are steadily activated in HCC. Although the …
- 206010028980 Neoplasm 0 title abstract description 39
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation; Therapies using these preparations
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Guo et al. | Cuproptosis induced by ROS responsive nanoparticles with elesclomol and copper combined with αPD‐L1 for enhanced cancer immunotherapy | |
| Kerstetter-Fogle et al. | Plant virus-like particle in situ vaccine for intracranial glioma immunotherapy | |
| Gao et al. | Selenium‐containing nanoparticles combine the NK cells mediated immunotherapy with radiotherapy and chemotherapy | |
| Sarvarian et al. | Application of emerging plant-derived nanoparticles as a novel approach for nano-drug delivery systems | |
| Dai et al. | Targeting CAMKII to reprogram tumor-associated macrophages and inhibit tumor cells for cancer immunotherapy with an injectable hybrid peptide hydrogel | |
| Dias et al. | Superparamagnetic iron oxide nanoparticles for immunotherapy of cancers through macrophages and magnetic hyperthermia | |
| Cai et al. | Plant-derived exosomes as a drug-delivery approach for the treatment of inflammatory bowel disease and colitis-associated cancer | |
| Yu et al. | Myeloid‐derived suppressor cell membrane‐coated magnetic nanoparticles for cancer theranostics by inducing macrophage polarization and synergizing immunogenic cell death | |
| Zhao et al. | Radiotherapy-mediated immunomodulation and anti-tumor abscopal effect combining immune checkpoint blockade | |
| Zhang et al. | Reduction sensitive polymers delivering Cationic platinum drugs as STING agonists for enhanced chemo‐immunotherapy | |
| Ou et al. | Enhanced targeting and immune activation of tumor microenvironment by nanomodified Anti‐PD1 in liver cancer | |
| Li et al. | The microbiota maintain homeostasis of liver-resident γδT-17 cells in a lipid antigen/CD1d-dependent manner | |
| Qiu et al. | Antitumor activity of cabazitaxel and MSC-TRAIL derived extracellular vesicles in drug-resistant oral squamous cell carcinoma | |
| Ye et al. | In situ generation of gold nanoparticles on bacteria‐derived magnetosomes for imaging‐guided starving/chemodynamic/photothermal synergistic therapy against cancer | |
| Scheetz et al. | Synthetic HDL nanoparticles delivering docetaxel and CpG for chemoimmunotherapy of colon adenocarcinoma | |
| Yu et al. | High intensity focused ultrasound‐driven nanomotor for effective ferroptosis‐immunotherapy of TNBC | |
| Nascimento et al. | Immunotherapy for cancer: effects of iron oxide nanoparticles on polarization of tumor-associated macrophages | |
| Gao et al. | Cancer nanobombs delivering artoxplatin with a polyigniter bearing hydrophobic ferrocene units upregulate PD‐L1 expression and stimulate stronger anticancer immunity | |
| Nie et al. | Mannose and hyaluronic acid dual-modified iron oxide enhances neoantigen-based peptide vaccine therapy by polarizing tumor-associated macrophages | |
| Liu et al. | Selenium nanoparticles enhance NK cell‐mediated tumoricidal activity in malignant pleural effusion via the TrxR1‐IL‐18RAP‐pSTAT3 pathway | |
| Andón et al. | Innate and adaptive responses of intratumoral immunotherapy with endosomal toll-like receptor agonists | |
| He et al. | Immunogenic cell death induced by chemoradiotherapy of novel pH-sensitive cargo-loaded polymersomes in glioblastoma | |
| Sun et al. | Combined photothermal therapy and Lycium barbarum polysaccharide for topical administration to improve the efficacy of doxorubicin in the treatment of breast cancer | |
| Zhao et al. | Neutrophil membrane-coated nanoparticles for enhanced nanosecond pulsed electric field treatment of pancreatic cancer | |
| Lu et al. | Simultaneous delivery of doxorubicin and EZH2‐targeting siRNA by vortex magnetic nanorods synergistically improved anti‐tumor efficacy in triple‐negative breast cancer |